Insmed, Inc. (NASDAQ:INSM)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs.

Featured Broker Partners


Advertisement